These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23328570)

  • 1. CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers.
    Fontana M; Barison A; Botto N; Panchetti L; Ricci G; Milanesi M; Poletti R; Positano V; Siciliano G; Passino C; Lombardi M; Emdin M; Masci PG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):124-6. PubMed ID: 23328570
    [No Abstract]   [Full Text] [Related]  

  • 2. Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy.
    Holmström M; Kivistö S; Heliö T; Jurkko R; Kaartinen M; Antila M; Reissell E; Kuusisto J; Kärkkäinen S; Peuhkurinen K; Koikkalainen J; Lötjönen J; Lauerma K
    J Cardiovasc Magn Reson; 2011 Jun; 13(1):30. PubMed ID: 21689390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: possible substrate for diastolic dysfunction.
    Raman SV; Sparks EA; Baker PM; McCarthy B; Wooley CF
    J Cardiovasc Magn Reson; 2007; 9(6):907-13. PubMed ID: 18066751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk prediction of ventricular arrhythmias and myocardial function in Lamin A/C mutation positive subjects.
    Hasselberg NE; Edvardsen T; Petri H; Berge KE; Leren TP; Bundgaard H; Haugaa KH
    Europace; 2014 Apr; 16(4):563-71. PubMed ID: 24058181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
    Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
    Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
    Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
    Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ventilatory response to exercise in symptomatic and asymptomatic LMNA mutation carriers: a follow-up study.
    Ollila L; Heliö T; Sovijärvi A; Jalanko M; Kaartinen M; Kuusisto J; Kärkkäinen S; Jurkko R; Reissell E; Palojoki E; Piirilä P
    Clin Physiol Funct Imaging; 2017 Jan; 37(1):8-16. PubMed ID: 27966284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
    van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
    Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations.
    Hermida-Prieto M; Monserrat L; Castro-Beiras A; Laredo R; Soler R; Peteiro J; Rodríguez E; Bouzas B; Alvarez N; Muñiz J; Crespo-Leiro M
    Am J Cardiol; 2004 Jul; 94(1):50-4. PubMed ID: 15219508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for comprehensive cardiac and neurologic assessment of lamin A/C mutation carriers.
    Stöllberger C; Finsterer J
    Radiology; 2009 Apr; 251(1):305-6; author reply 306. PubMed ID: 19332860
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
    Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
    Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
    Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
    J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - yes].
    Thanaraj A; Meder B
    Dtsch Med Wochenschr; 2013 Mar; 138(12):598. PubMed ID: 23483421
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: demand for strategies in the management of presymptomatic lamin A/C mutant carriers.
    Perrot A; Sigusch HH; Nägele H; Genschel J; Lehmkuhl H; Hetzer R; Geier C; Leon Perez V; Reinhard D; Dietz R; Josef Osterziel K; Schmidt HH
    Eur J Heart Fail; 2006 Aug; 8(5):484-93. PubMed ID: 16386954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early familial dilated cardiomyopathy: identification with determination of disease state parameter from cine MR image data.
    Koikkalainen JR; Antila M; Lötjönen JM; Heliö T; Lauerma K; Kivistö SM; Sipola P; Kaartinen MA; Kärkkäinen ST; Reissell E; Kuusisto J; Laakso M; Oresic M; Nieminen MS; Peuhkurinen KJ
    Radiology; 2008 Oct; 249(1):88-96. PubMed ID: 18796670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.